Library
2-PTA
Human data remain extremely limited (≤50 self-reports). Acute adverse effects recorded include marked tachycardia (>130 bpm), vasoconstriction, jaw tension, blurred vision and short-lived chest discomfort at ≥60 mg. Because the amide replaces the α-methyl, potency is roughly one-quarter of amphetamine but pressor effects are still pronounced. Neurotoxicity has not been assessed; amphetamine-like oxidative stress is plausible at high temperatures or long binges - keep body temperature <38°C and supplement antioxidants (e.g., 500 mg vitamin C). Always perform an allergy test ≤1 mg.
Also known as: Cumylamine, 4-methyl-2-pa
Classification
- Psychoactive: Stimulant
- Tag: Alkyl amine
- Tag: Habit-Forming
- Tag: Research-Chemical
- Tag: Tentative
Effects
- Stimulation
- Tachycardia
- Increased Blood Pressure
- Vasoconstriction
- Teeth Grinding
- Temperature Regulation Suppression
- Euphoria
- Focus Enhancement
- Increased Sociability
- Anxiety
- Cognitive Fatigue
- Motivation Enhancement
- Increased Libido
- Appetite Suppression
- Light Sensitivity
Routes of Administration
Oral
Dosage
- Threshold: 5 mg
- Light: 10-20 mg
- Common: 20-40 mg
- Strong: 40-80 mg
- Heavy: 80 mg
Duration
- Onset: 0.17-0.42 h
- Peak: 0.75-1.5 h
- Offset: 0.5-1 h
- After Effects: 1-6 h
Insufflated
Dosage
- Threshold: 2 mg
- Light: 5-10 mg
- Common: 10-20 mg
- Strong: 20-40 mg
- Heavy: 40 mg
Duration
- Onset: 0.03-0.13 h
- Peak: 0.75-1.5 h
- Offset: 0.5-1 h
- After Effects: 1-6 h
Sublingual
Dosage
- Threshold: 5 mg
- Light: 10-15 mg
- Common: 15-30 mg
- Strong: 30-60 mg
- Heavy: 60 mg
Duration
- Peak: 0.75-1.5 h
- Offset: 0.5-1 h
- After Effects: 1-6 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
